Works matching IS 15391604 AND DT 2014 AND VI 13 AND IP 4

Results: 9

Subgroup analyses in cost-effectiveness analyses to support health technology assessments.
Published in:
Pharmaceutical Statistics, 2014, v. 13, n. 4, p. 265, doi. 10.1002/pst.1626
By:
- Fletcher, Christine;
- Chuang‐Stein, Christy;
- Paget, Marie‐Ange;
- Reid, Carol;
- Hawkins, Neil
Publication type:
Article
Missing data sensitivity analysis for recurrent event data using controlled imputation.
Published in:
Pharmaceutical Statistics, 2014, v. 13, n. 4, p. 258, doi. 10.1002/pst.1624
By:
- Keene, Oliver N.;
- Roger, James H.;
- Hartley, Benjamin F.;
- Kenward, Michael G.
Publication type:
Article
Drug development: EU paediatric legislation, the European Medicines Agency and its Paediatric Committee-adolescents' melanoma as a paradigm.
Published in:
Pharmaceutical Statistics, 2014, v. 13, n. 4, p. 211, doi. 10.1002/pst.1623
By:
- Rose, Klaus;
- Senn, Stephen
Publication type:
Article
When is a seamless study desirable? Case studies from different pharmaceutical sponsors.
Published in:
Pharmaceutical Statistics, 2014, v. 13, n. 4, p. 229, doi. 10.1002/pst.1622
By:
- Cuffe, Robert L.;
- Lawrence, David;
- Stone, Andrew;
- Vandemeulebroecke, Marc
Publication type:
Article
Benefit-risk assessment in pharmaceutical research and development.
Published in:
Pharmaceutical Statistics, 2014, v. 13, n. 4, p. 275, doi. 10.1002/pst.1627
By:
- Haddad, Jonathan
Publication type:
Article
Data-driven treatment selection for seamless phase II/III trials incorporating early-outcome data.
Published in:
Pharmaceutical Statistics, 2014, v. 13, n. 4, p. 238, doi. 10.1002/pst.1619
By:
- Kunz, Cornelia Ursula;
- Friede, Tim;
- Parsons, Nick;
- Todd, Susan;
- Stallard, Nigel
Publication type:
Article
A Bayesian dose-finding design for drug combination clinical trials based on the logistic model.
Published in:
Pharmaceutical Statistics, 2014, v. 13, n. 4, p. 247, doi. 10.1002/pst.1621
By:
- Riviere, Marie‐Karelle;
- Yuan, Ying;
- Dubois, Frédéric;
- Zohar, Sarah
Publication type:
Article
Statistical considerations associated with a comprehensive regulatory framework to address the unmet need for new antibacterial therapies.
Published in:
Pharmaceutical Statistics, 2014, v. 13, n. 4, p. 222, doi. 10.1002/pst.1625
By:
- Dane, Aaron;
- Wetherington, Jeffrey D.
Publication type:
Article
Can a treatment be licenced on the basis of post-treatment predictive biomarkers?
Published in:
Pharmaceutical Statistics, 2014, v. 13, n. 4, p. 214, doi. 10.1002/pst.1620
By:
- Stone, Andrew;
- Schmitt, Nicola
Publication type:
Article